National Institute of Diabetes and Digestive and Kidney Diseases Seeks Licensees for HCV Vaccine Development

Summary

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) at the National Institutes of Health (NIH) is offering a licensing opportunity and/or Cooperative Research and Development Agreement (CRADA) to develop a Hepatitis C virus (HCV) vaccine based on the synthesis and purification of non-infectious HCV-like particles containing HCV structural proteins.